Table 2 Main baseline demographic and clinical characteristics according to the diabetic macular edema (DME) subtypes
Characteristic | DRT (n = 20) | CME (n = 41) | SRD (n = 23) | Pa |
|---|---|---|---|---|
Age, years | ||||
Mean (SD) | 72.5 (7.2) | 72.4 (8.7) | 67.6 (10.9) | 0.0987 |
95% CI | 69,1 to 75,8 | 69.6 to 75.2 | 62.9 to 72.3 | |
HbA1c, (%) | ||||
Mean (SD) | 7.4 (0.9) | 7.6 (1.0) | 7.7 (0.8) | 0.7371 |
95% CI | 7.0 to 7.9 | 7.3 to 7.9 | 7.3 to 8.0 | |
Sex, n (%) | ||||
Man | 14 (70.0) | 25 (61.0) | 19 (82.6) | 0.1981b |
Woman | 6 (30.0) | 16 (39.0) | 4 (17.4) | |
Eye, n (%) | ||||
Right | 12 (60.0) | 19 (46.3) | 14 (60.9) | 0.4303b |
Left | 8 (40.0) | 22 (53.7) | 9 (39.1) | |
Type of patient, n (%) | ||||
Naïve | 6 (30.0) | 13 (31.7) | 10 (43.5) | 0.5653b |
Non-naïve | 14 (70.0) | 28 (68.3) | 13 (56.5) | |
Visual Acuity** | ||||
Mean (SD) | 64.8 (10.1) | 58.8 (16.2) | 60.9 (14.6) | 0.3272 |
95% CI | 60.0 to 69.5 | 53.7 to 63.9 | 54.5 to 67.2 | |
Number of anti-VEGF injections | ||||
Mean (SD) | 5.3 (4.9) | 5.1 (4.9) | 3.1 (3.2) | 0.1877 |
95% CI | 3.0 to 7.6 | 3.5 to 6.6 | 1.7 to 4.5 | |
CMT, μm | ||||
Mean (SD) | 352.6 (38.4) | 459.4 (141.8)* | 533.8 (149.2)* | < 0.0001 |
95% CI | 334,6 to 370,6 | 414,7 to 504,2 | 469,3 to 598,3 | |